Genetically engineered mice (GEM) have become invaluable tools for human disease modeling and drug development. Completion of the mouse genome sequence in combination with transgenesis and gene targeting in embryonal stem cells have opened up unprecedented opportunities. Advanced technologies for derivation of GEM models will be introduced and discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-60761-058-8_4 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!